| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Cellistic Delivering the iPSC platforms that ready the world for next-gen cell therapies Launched in April 2022, Cellistic specializes in process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The company’s focus and expertise in iPSC generation and differentiation protocol development makes it well-positioned to partner with innovative cell therapy developers to establish novel advanced therapies. With more than a decade of scientific and technical knowledge transfer from sister company Ncardia, Cellistic is uniquely experienced in designing and optimizing manufacturing procedures for iPSCs that deliver quality products at scale. For more information, visit www.cellistic.com. Type: | 0 | 0 | 0 | 94 |
 |  USC The official Twitter account of the University of Southern California. #USC | #FightOn Type: | 53 | 13 | 8 | N/A |
 |  Predilife Prédire pour prévenir - Bilans prédictifs permettant d'identifier le risque de maladies graves Pioneers of predictive medicine in France, we position ourselves as a player in 6P medicine: Predictive, Preventive, Personalized, Participative, Relevant, Multi-professional. After 14 years of research and development, Predilife obtained its medical device certification and began marketing predictive assessments: predictive breast cancer assessment, multi-pathology predictive assessments. At Predilife, we are passionate about serving health, a committed team that works every day to change the rules so that our motto "predict to prevent" is adopted by the greatest number of people. We accompany companies, healthcare professionals and employees … Type: | 23 | 4 | 20 | 30 |
 | Biom'up Innovative Biosurgery Founded in 2005 and based in the Lyon suburb of Saint-Priest (France), Biom’up develops and commercializes hemostatic products based on patented biopolymers designed to simplify traditional and laparoscopic surgical procedures in numerous specialties such as cardiac, general and orthopedic, and give patients a better quality of life. The Company’s lead product, HEMOBLASTTM Bellows, is marketed in Europe and the United States. Biotechnologie, Dispositifs Médicaux Implantables, Collagène, Equipements médicaux, Hémostase, Innovative biosurgery, Medical devices, Hemostasis, Collagen, Biotechnology, Pharmacy, Hemoblast, hemostatic, medical devices, and hemostasis Type: | 3 | 1 | 2 | 37 |
 | Histalim A division of Cerba Research For nearly 10 years HISTALIM provides services in the fields of histology, cytology and molecular biology for clients from a wide range of sectors including human and animal health, dermo-cosmetics, chemistry, environment, agronomics, agri-food industry... Ranging from neurosciences to toxicity assessment, from the characterization of therapeutic antibodies to the evaluation of implantable medical devices..., our teams focus on accompanying each client to provide each of them with a perfectly controlled service. Our histological technical resources, our European network of histopathology experts, and our techniques in image processing and analysis enable us to meet efficiently each … Type: | 4 | 1 | 4 | 12 |
 | GLYcoDiag Glycoscience research specialized company GLYcoDiag is a French research company (SME) specialized in glycobiology and glycoanalysis projects and products . GLYcoDiag has a recognized expertise related to his technology intended for the determination of interaction profiles with lectins allowing to identify "glycans signatures" (GLYcoPROFILE) or oligosaccharides receptors on the surface of molecules or cells . The technology associated with others methods of structural analysis and the expertise of the company in the field of glycobiology, constitute a complete platform, suitable for the study of molecules, cells or the action of a glycosylated molecule in the biological recognition processes between lectins … Type: | 1 | 0 | 0 | 4 |
 | EDELRIS We focus our effort to create value for your projects. EDELRIS is a pioneering company dedicated to the design and chemical synthesis of innovative natural product-like screening Libraries, medicinal chemistry Hit-to-Lead / Lead Optimization projects, Custom Synthesis, and Affinity screening-Mass Spectrometry (AS-MS). Aiming at the acceleration of the lead discovery and optimization process in pharma and biotech research organizations, EDELRIS uses its recognized chemistry and screening expertise in drug discovery to provide novelty to its clients and partners. Our unique and first-in-class NP-like, easily tractable screening libraries (Fragments, Covalent binders, conventional HTS & DEL) now contain +2M in-house synthesized compounds, … Type: | 7 | 1 | 7 | 62 |
 | Eurofins BIO-EC [Automatic translation follows] French laboratory specializing in studies of the efficacy of cosmetic and dermatological products for 24 years 🔬 Since 1998, the BIO-EC Laboratory has specialized in evaluating the efficacy of cosmetic and dermatological products (finished products or active ingredients), but also medical devices and food supplements. Our activity is organized around several areas: 🔸 Ex vivo studies on human skin explants kept alive 🔸 In vivo studies on a panel of healthy volunteers 🔸 Skin absorption studies 🔸 RAMAN spectroscopy studies 🔸 Cosmetogenomics studies All of the studies we carry out are customizable in order to best meet … Type: | 1 | 0 | 1 | 33 |
 | AB Science AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. We are innovators and scientific entrepreneurs in the field of life science. Our group is specialized in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical needs in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. Our pipeline is both in Human and Veterinary medicine. Our drugs are … Type: | 2 | 1 | 0 | 87 |
 | OMEICOS Therapeutics GmbH Developing 1st-in-class therapeutics based on the profound understanding of omega-3 fatty acid metabolism OMEICOS Therapeutics has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids that have the potential to treat mitochondrial dysfunction, inflammatory, cardiovascular and other diseases. Epoxyeicosanoids activate cell type-specific endogenous pathways that promote organ and tissue protection. OMEICOS’ small molecules are orally available and show improved biological activity and pharmacokinetic properties compared to their natural counterparts. The currently active PMD-OPTION Phase 2a clinical study is evaluating OMEICOS’ lead development program OMT-28 in patients with Primary Mitochondrial Disease. Drug development, Cardiovascular Research, and Mitochondrial … Type: | 3 | 1 | 2 | 9 |
 | RetroBrain R&D GmbH/ SilverFit GmbH Spielend körperlich und geistig aktiv sein Retrobrain is researching and developing novel serious gaming approaches to solve challenges in medical care and therapy with a particular focus on the elderly, Alzheimer's disease as well as motion/gesture based control schemes utilizing Kinect and other motion-sensing equipment. More generally, we are working with researchers and teams around the world to explore how serious therapeutic games can best be used to improve mental and physical health and to alleviate or prevent illness. We are currently implementing our award-wining proof-of-concept with technology partners including Microsoft Germany, research partners at the Humboldt University of Berlin, … Type: | 3 | 1 | 2 | 15 |
 | Instituto de Biología Molecular y Celular de Plantas, IBMCP (UPV - CSIC) [Automatic translation follows] Discovering from green - Scientific research aimed at obtaining plants with better productivity, fruit quality or with high added value properties (of interest to the consumer, farmers and the agri-food industry) and more resistant to stress, as well as less dependent on chemical treatments, thus contributing to a less aggressive agriculture with the environment. - Advanced services in Genomics, Proteomics, Metabolomics, Bioinformatics, Microscopy, Quantification of Plant Hormones, DNA Sequencing and Gene Expression Analysis. - Training of research staff. Biotechnology, Molecular Biology, Genomics, Proteomics, Bioinformatics, Metabolomics, Systems Biology, and Synthetic Biology Type: | 3 | 0 | 0 | 191 |
 | AMSBIO AMSBIO is a global supplier of research products and custom services for biological and pharmaceutical research Accelerate your discovery with exceptional service and innovative, cutting-edge life science products Founded over 35 years ago, AMSBIO is a premier life sciences supplier dedicated to meeting diverse research needs. AMSBIO’s product lines are carefully curated with top tier products to give high choice and quality control, as well as offering advanced, flexible and tailored custom services. In addition, AMSBIO’s focus on generally underserved areas, such as Glycobiology, highlights a wider mission to advancing niche fields in life science. AMSBIO is ISO9000 Certified to … Type: | 2 | 0 | 2 | 32 |
 | DiaMonTech AG Say goodbye to finger pricking! Awarded for “most innovative German startup” from German business magazine Bilanz, DiaMonTech has developed a medical device that non-invasively measures your blood glucose without finger pricking, a drop of blood, or a test strip. Simply relax your fingertip on the sensor, wait 5 to 15 seconds, and your blood glucose level will be displayed. Our patented technology works with an invisible infrared light beam that looks into your skin and counts glucose molecules. Diabetes is a global challenge. More than 400 million people worldwide suffer from the disease. Our goal is to make checking your … Type: | 0 | 0 | 0 | 27 |
 | Naturae [Automatic translation follows] Europe's first biofactory dedicated to obtaining natural and healthy products based on biotechnology. Naturae © is a set of ingredients that can be added to all types of food and drink and that, among other beneficial effects for our health, safely and naturally activate the immune system, enhance cholesterol control and improve cardiovascular circulation. Naturae © is obtained from proprietary and registered strains of natural mushrooms, such as shiitake or yeast. It is completely free of genetically modified organisms (GMO) and its extraction is carried out naturally, using patented methods, without the addition of synthetic substances. Naturae … Type: | 1 | 0 | 0 | 35 |
 | Dewpoint Therapeutics Translating condensate biology into medicine. Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has multiple programs across an ambitious pipeline spanning oncology, neurodegeneration, cardiopulmonary, and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck, and Pfizer. Dewpoint scientists work in Boston, Dresden and Frankfurt to translate condensate biology into breakthrough treatments for diseases previously considered untreatable. biomolecular condensates, oncology, neurodegeneration, cardiopulmonary, virology, insulin resistance, … Type: | 3 | 0 | 2 | 128 |
 | Optimum Nutrition Leader in the sports nutrition industry empowering people everywhere to realize their potential and achieve their goals. Optimum Nutrition, Inc. (ON) is part of the Glanbia global nutrition group and has been setting the Gold Standard in sports nutrition for more than 30 years - helping performance focused athletes achieve their goals We are the creators of 100% Whey Protein (The Worlds #1 Protein Powder), Gold Whey Standard 100% Casein, Essential Amino Energy, Diet Products, Strength and Recovery Supplements, and other health and nutrition products. Type: | 1 | 1 | 0 | 96 |
 | Havas Life Rare The Premier Commercialization and Marketing Partner for Orphan Drugs and Rare Disease Markets Worldwide Havas Life Rare is the premier commercialization and marketing partner for orphan drugs and rare disease markets. In a setting where natural history, diagnosis, care pathways, awareness, and access are almost always underdeveloped, it takes rigorous strategic thinking, deep medical knowledge, and extensive rare disease commercial experience to navigate the right path forward. Type: | 4 | 1 | 1 | 37 |
 | Xkelet We develop Medical Device Software for professionals to produce personalized products using AI to automatize the process We want to change the current immobilization methods such as plaster and current orthotic systems, to solve the problems that come from these immobilization systems. The immobilizations are printed with 3D printing technology and suitable for accurate measurements of the patient's anatomy. With Xkelet, the patient can shower and dry without problems, no longer scratching due to scaling of the skin, in case the injury includes a wound already well derived by the fracture itself as an operative process, the patient and the … Type: | 4 | 0 | 3 | 16 |
 | Apprentice.io Release your next batch faster. AI-powered cloud platform for batch-based manufacturing. Apprentice’s Tempo Manufacturing Cloud is the first AI-powered cloud platform for batch-based manufacturing. Tempo connects your teams, systems, sites, and external partners across one cloud-based platform to provide seamless processing through every layer of your manufacturing ecosystem. By combining historically distributed systems — Manufacturing Execution System (MES), Distributed Control System (DCS), Laboratory Execution System (LES), eLogs, Work Instructions, Tempo optimizes end-to-end manufacturing processes. AI is embedded in every step of the process, driving innovation from design to creation, through to simulation and execution, delivering the power of the next … Type: | 10 | 0 | 2 | 114 |
 | Causeway Sensors Limited Causeway Sensors uses nanotechnology to provide better candidate selection during drug development. The company spun-out after years of high-impact research at Queen's University Belfast. Our unique nanochip platform brings real-time, label-free kinetic analysis to areas of biotherapeutic production where such data cannot currently be collected. More data at critical points of production helps pharma companies ensure that only the best drug candidates progress to clinical trials. The platform can be incorporated into a multitude of form factors, ranging from a high-throughput screening instrument to an in-line cell culture monitoring tool. Biosensing, Protein - Protein Interactions, Binding Kinetics, Biotechnology, Biotherapeutics, Antibody … Type: | 3 | 0 | 2 | 12 |
 | MSD Italia [Automatic translation follows] We have always invented for one great purpose: Life We have always invented for one great purpose: Life MSD, known in the United States and Canada as Merck & Co., Inc., with headquarters in Kenilworth, (New Jersey, USA), is an American multinational leader in the pharmaceutical sector. For over 65 years in Italy and 130 in the world, we have revolutionized therapeutic paradigms for dozens of pathologies through the discovery of over 200 innovative molecules. Our mission is to discover, develop, make available innovative products and services that save and improve the lives of Patients around the … Type: | 12 | 0 | 5 | 534 |
 | WCG We improve lives by accelerating research, together. WCG is a true partner to research sponsors, CROs, sites and participants in navigating the clinical research journey. The pioneer of independent ethical review, now the industry gold standard, WCG’s 55-year legacy of independent review solutions serves as the foundation on which we continually build to accelerate and improve the clinical research journey. We lead the way by reimagining processes, optimizing quality and safety, strengthening productivity, and pioneering new solutions that leverage data and technology to accelerate research and impact global health. WCG liberates study stakeholders from the constraints that risk trial efficacy … Type: | 2 | 0 | 2 | 1,347 |
 | FairJourney Biologics Your trusted partner for innovative, end-to-end antibody services At FairJourney Biologics, we specialize in cutting-edge antibody discovery and development, offering end-to-end solutions that fast-track your research. With over a decade of expertise, our innovative technologies and seasoned team have successfully advanced 14 antibodies to clinical stages. Our adaptable partnership model empowers projects of any scale, fostering collaboration and breakthrough innovation. Whether you're in early-stage research or development, we deliver tailored, high-quality antibodies designed to meet your specific needs. Join us in revolutionizing therapeutic discovery and making lasting impacts on global healthcare. Monoclonal antibodies, Antibody humanization, Antibody production, Antibody affinity maturation, … Type: | 2 | 0 | 1 | 284 |
 | Dragonfly Therapeutics, Inc. Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas. For more information, email info@dragonflytx.com. immuno-oncology Type: | 4 | 0 | 1 | 124 |
 | AVROBIO Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring personalized gene therapy worldwide Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients’ own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato® gene therapy platform is scalable for planned global commercialization. … Type: | 3 | 1 | 0 | 58 |
 | Skyhawk Therapeutics We Use Small Molecules To Modify RNA Splicing Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that modify RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted toward cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com. Type: | 3 | 0 | 1 | 69 |
 |  Korro Bio, Inc. Edit the message. Rewrite the future. Pioneering RNA editing to deliver the future of medicine. Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body’s natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function, addressing the medical needs of patients. Our mission is to rewrite the future for patients living with debilitating disease by repairing the underlying genetic cause. Type: | 3 | 0 | 2 | 106 |
 | Apollomics We are a biopharmaceutical company committed to the discovery and development of mono- and combination cancer therapies. Apollomics is an innovative biotechnology company committed to the discovery and development of oncology combination therapies. With operations in both the U.S. and China, we believe we are well positioned to unlock synergies by leveraging the strengths of partnerships with other biotechnology companies in the East and the West. Since our founding in 2015, under the leadership of our experienced management team with in-depth knowledge and expertise of the evolving cancer treatment landscape, we have built a pipeline of ten (10) drug candidates … Type: | 1 | 0 | 1 | 24 |
 | Poseida Therapeutics, Inc. The Capacity to Cure Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes investigational allogeneic CAR-T cell therapies for both solid tumors and hematologic cancers as well as investigational in vivo genetic medicines that address patient populations with high unmet medical need. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVERTM Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing. … Type: | 3 | 0 | 3 | 349 |
 | Civica Rx Serving patients is a privilege that comes with significant responsibilities. Civica Rx was created in late 2018 to secure the supply of important medicines hospitals use every day. As of Q2 2024, we have provided over 180 million units of essential medicines to hospitals, enough to help treat over 80 million patients. Recently, we announced we will manufacture and distribute affordable medications for consumers in an outpatient/retail setting, including affordable insulin. Insulin is an exciting project as we are partnering with nearly every corner of the diabetes ecosystem to bring low-cost insulin to people living with diabetes at no more … Type: | 1 | 0 | 0 | 188 |
 | Abzena Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, … Type: | 7 | 0 | 1 | 446 |
 | Voyager Therapeutics, Inc. Breaking through barriers in gene therapy and neurology Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACERTM AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs … Type: | 3 | 0 | 2 | 200 |
 | NovioSense BV NovioSense BV is a spin out company from Fraunhofer Gesellschaft and NovioTech BV based in Nijmegen. NovioSense is a wireless platform technology for non-invasive monitoring of disease biomarkers. The first sensor based on the NovioSense technology is a wireless non-invasive glucose sensor. Development is targeted at a clinical prototype for non-invasive continuous monitoring of glucose levels in tear fluid. Medical Devices, Sensor Development, Diabetes, and Medical Technology Type: | 0 | 0 | 0 | N/A |
 | Precigen Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of gene and cell therapies. Precigen: Advancing Medicine with PrecisionTM Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and … Type: | 0 | 0 | 0 | 114 |
 | Sen-Jam Pharmaceutical We’re changing the way the world treats inflammation and the way the pharma industry treats humanity Join the revolution! We’re changing the way the world treats inflammation and the way the pharma industry treats humanity. Invest today → https://wefunder.com/senjam Sen-Jam's Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph. It's time for a stronger, more resilient world, free of side-effects and filled with living remarkably Inflammation , Wellbeing, Pain Relief, pharmaceutical, and healthcare Type: | 0 | 0 | 0 | 12 |
 | coIMMUNE, Inc. coIMMUNE is a privately held, clinical stage immune-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies. Our allogeneic CAR-CIK technology platform for liquid and solid tumors is a novel CAR therapy that promises enhanced efficacy with greatly reduced toxicity. Type: | 5 | 2 | 3 | 8 |
 | InCarda Therapeutics Pioneering inhaled medications for cardiovascular conditions InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF). Cardiovascular, Inhalation therapy, Biotechnology, Pharmaceuticals, Clinical Development, Drug Formulation, Commercialization, Clinical Research, Pre-Clinical Research, and Regulatory Affairs Type: | 1 | 0 | 0 | 15 |
 | MindMed MindMed is a clinical-stage biopharma company developing novel products to treat brain health disorders MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems. MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the … Type: | 4 | 0 | 3 | 102 |
 | American Gene™ A cell & #genetherapy company with a #gene delivery platform to develop cures to #cancer #HIV #PKU. In Phase 1 trial for #HIVcure. CEO @JeffreyGalvin. Type: | 1 | 0 | 0 | N/A |
 | Insmed Incorporated Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. We are dedicated to making a meaningful impact in patients’ lives as well as the communities where we live and work. Our team is guided by our core values of collaboration, accountability, passion, respect, and integrity. Insmed is headquartered in Bridgewater, NJ, and has offices and research locations throughout the United States, Europe, and Japan. We are proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending three consecutive years as … Type: | 3 | 0 | 2 | 1,185 |
 | Crinetics Pharmaceuticals Discovering drugs for endocrine diseases and endocrine-related tumors. #acromegaly #crinetics #CarcinoidSyndrome This place is about more than a pharmaceutical career. It’s about making a real difference in the lives of patients. That’s why we’re here. That’s why you should maybe think about being here, too. Our mission is to build the leading endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. Working to accomplish this mission is how we bring our vision to life. For us, that vision is the best possible therapeutics available to all patients with diseases of … Type: | 3 | 0 | 1 | 355 |
 | Ceva Ridgeway Biologicals Ltd Autogenous Vaccines Specialists Ridgeway Biologicals are licensed by the VMD (Veterinary Medicines Directorate) to manufacture autogenous vaccine which are veterinary prescription only medicines. Autogenous vaccines are prepared from a pathogen extracted from a host animal or group which is then used to inoculate the rest of the group. We are able to manufacture autogenous vaccine for many farm animals and fish. For more information on autogenous vaccines please contact your veterinary surgeon. autogenous veterinary vaccines Type: | 1 | 0 | 1 | 24 |
 | SafeHeal Reshaping RecoveryTM Established in 2015 and based in France, SafeHealTM is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented by French surgeon Charam Khosrovani to eliminate the need for diverting ostomies in patients undergoing colectomy. medical device Type: | 2 | 1 | 0 | 19 |
 | BIOGARAN [Automatic translation follows] The box that takes care of you. French drug laboratory 🇫🇷 Biogaran was founded in 1996, to specifically respond to the development of a new, still little-known market: generic drugs. Offering patients quality drugs with recognized effectiveness whose patent had fallen into the public domain was then a new type of know-how that traditional laboratories did not possess. Our know-how is available through different ranges: from minor everyday ailments with the Biogaran Conseil® range, to more serious pathologies with prescription drugs. Whatever the pathology, patient health is at the heart of Biogaran's concerns and the same rigor … Type: | 10 | 3 | 6 | 535 |
 | Laboratoires Théa Théa, Let's Open Our Eyes Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries. Ophthalmology, Pharmaceuticals, Medical Devices, Eye care, Eye Health, and Preservative-free Type: | 11 | 6 | 5 | 811 |
 | OZ Biosciences OZ Biosciences creates, develops and commercializes life sciences reagents specialized in transfection and transduction OZ Biosciences is a product development company that creates, develops and commercializes delivery systems of bioactive materials (DNA, siRNA, proteins, antibodies...), intended for the worldwide scientific community and pharmaceutical industries. Our mission is to assist scientists to accelerate the rhythm of discoveries by offering them technologically advanced tools such as transfection reagents and other life science research products. Principal innovations are based on propietary technologies such as Magnetofection (magnetic-assisted transfection or infection), Magneto-Biolistic, transfection reagents, transduction tools, mRNA and lipids-based delivery systems (LNP). Specialized and expert … Type: | 3 | 1 | 2 | 18 |
 | genOway Together, we science better Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom … Type: | 5 | 3 | 1 | 109 |
 | EDAP TMS Bringing New Horizons to Therapy EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and … Type: | 6 | 1 | 4 | 199 |
 | National Pork Board People. Pigs. Planet. We’re proud to support pork producers. Our team works every day to do what’s right for people, pigs, and the planet. The National Pork Board is a consumer-focused, producer-led organization that focuses on research, promotion and education to ensure the longevity of pork as a sustainable, nutritious protein. We lead the pork industry as a catalyst and connector to add value and build trust among those who produce, process, sell and consume pork. We strongly support our diverse workforce in many ways by fostering an inclusive and inviting environment. Please consider joining our team if this is … Type: | 8 | 3 | 4 | 135 |
 | Epigenica Bringing the first multiplex, high-throughput tools to epigenomic research Epigenica is a life sciences technology company at the forefront of innovations in epigenetic research. The company’s EpiFinder platform enables researchers to perform comprehensive epigenetic studies at unprecedented speed, scalability, and affordability. Epigenica is building a portfolio of products based on the EpiFinder platform to offer comprehensive high-throughput profiling at different depths of detail with an array of possible starting materials. The platform is powered by the company’s patented and proprietary high-throughput, multiplex, quantitative ChIP-seq technology (hmqChIP), the first commercial kit of its kind. With the advantages of the EpiFinder platform, … Type: | 6 | 0 | 1 | 13 |
 | DryGro DryGro produces next-generation clean-label protein ingredients from Water Lentils DryGro is an agtech company building the future of plant protein. Working with our academic partners and world-class research team, we develop technology to produce Water Lentils, a clean label protein crop that can be produced sustainably at industrial scale. We envision a world where everyone has access to high quality protein that is produced in an environmentally and socially responsible way. Type: | 1 | 0 | 1 | 21 |
 | SingCell A stem cells Contract Development and Manufacturing Organisation (CDMO) in Singapore. MSC, iPSC, clean meat. SingCell offers process development and contract manufacturing services for stem cell therapy and clean meat companies. SingCell leverages its proprietary technology to improve manufacturing processes and offer high consistent quality stem cells. #cleanmeat #celltherapy Type: | 0 | 0 | 0 | 1 |
 | CollPlant Pioneering Regenerative Medicine CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, we are developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics. Our mission at CollPlant is to deliver ground-breaking … Type: | 1 | 0 | 0 | 72 |
 | Plantible We're hiring! Plantible Foods is a B2B food technology company with the goal to develop the most functional and applicable plant-based protein in the world using scalable and sustainable aqua-farming and extraction technologies Type: | 6 | 2 | 4 | 48 |
 | Imagindairy Dairy Done Differently Imagindairy, a Foodtech company, is addressing the industry bottleneck by integrating deep tech with system biology to develop a commercial and viable animal free protein-based dairy product Type: | 6 | 2 | 4 | 41 |
 | LightLife Plant-based food that powers you up, and never weighs you down. For over forty years, we have been creating high-quality, plant-based foods that taste as great as they make you feel and we promise to continue to do our best, so you can feel your best. Plant-Based Food, Vegan Food, Vegetarian Food, Tempeh, and Plant-Based Protein Type: | 2 | 0 | 1 | 61 |
 | INFORS HT Incubation shakers, bioreactors and bioprocess software for reliable and efficient cultivations. INFORS HT is your specialist for bioreactors, incubation shakers and bioprocess control software for reliable and efficient cultivations. You benefit from sophisticated systems, in which your cell lines or microorganisms develop their full potential in a reproducible way, thus contributing to your success. For your applications, we offer the right solutions: Fermentation of microorganisms (bacteria, fungi and yeasts) Cell culture (mammalian cells, insect cells, plant cells and algae) Biofuel (biodiesel and bioethanol) Parallel bioprocesses Custom-made bioreactors and incubation shakers Bioprocess control software Qualification of bioreactors and incubation shakers Closeness … Type: | 1 | 0 | 1 | 170 |
 | Chemglass Life Sciences Where chemistry meets biology. Chemglass was founded in a small garage in Newfield, New Jersey. The year was 1946. Today, Chemglass Life Sciences has grown into a total of 197,000 square feet, in an expansive, three-building complex located in Vineland, NJ. While scientific glassblowing gave us our start, we have expanded to include four major areas of concentration: scientific and OEM glassware manufacture, bioprocess cleanroom assembly, custom metal and plastic machining and electronics design engineering. We serve many markets. Our customers are typically found in the pharmaceutical, biopharmaceutical, and healthcare industries as well as in all levels of academia. Our … Type: | 0 | 0 | 0 | 106 |
 | V-dog, Inc Plant powered pooches save the planet! V-dog makes healthy, yummy food and treats for dogs without the need for animal products or factory farming. All v-dog products are sustainably made in the USA, making v-dog better for pooch and planet. Type: | 1 | 0 | 0 | 6 |
 | CellRev Proprietary media solutions to improve manufacturing efficiency I Biotools Innovator Cohort Member 2024 CellRev provide bioprocessing solutions to increase the efficiency of cell manufacturing. Our products leverage application specific IP to address significant bottlenecks in cell culture protocols including aggregation, clumping, cell detachment, and process translatability. We support our customers to take breakthrough treatments from discovery to manufacturing. Our media additives permit productivity and cost improvements in existing batch, fed-batch, and perfusion based bioprocesses. CellRev also offer a pioneering continuous processing platform for adherent cells, the Livit ACE. The invent of this platform represents one of the most meaningful breakthroughs … Type: | 4 | 1 | 3 | 14 |
 | Rousselot Rousselot is the global leader of gelatin and collagen-based solutions. Rousselot is Darling Ingredients' health brand. Rousselot: Reaching further together Rousselot is the global leader of collagen-based solutions* for the food, health and nutrition, biomedical and pharmaceutical sectors. We convert the full potential of the collagen molecule into solutions that sustain people’s health and well-being. Working in partnership with our global customer-base, we deliver advanced ingredient solutions that enable innovation, excite today’s consumers, and contribute to public health. Through our state-of-the-art operations, extensive technical expertise and sustained scientific research, we help our customers achieve their goals, create world-class products, and … Type: | 1 | 0 | 0 | 875 |
 | ABEC engineered solutions and services for biotech manufacturing ABEC engineered solutions and services for biotech manufacturing Since 1974, ABEC has been a global leader in delivering integrated process solutions and services for manufacturing in the biopharmaceutical industry. Many of today’s leading antibody, vaccine, and recombinant protein therapies are manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC, and a majority of the world’s pharmaceutical and biotech companies are ABEC customers. ABEC’s unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether building new capacity or improving existing facilities, ABEC’s turn-key … Type: | 1 | 0 | 1 | 494 |
 | RELIEF THERAPEUTICS Holding SA Providing relief to patients with unmet medical needs in select specialty and rare diseases. RELIEF THERAPEUTICS Holding SA (SIX: RLF; OTCQB: RLFTF, RLFTY) We are a biopharmaceutical company committed to providing therapeutic relief to patients living with rare diseases. Our goal is to advance treatment paradigms and deliver improvements in efficacy, safety and convenience to benefit the lives of patients and their families. Our therapeutic focus is on rare indications for metabolic disorders, pulmonary diseases, and dermatology/connective tissue disorders. Acute Lung Injury, Pulmonary Sarcoidosis, Lung Fibrosis, Acute Respiratory Distress Syndrome, Urea Cycle Disorders, Maple Syrup Urine Disease, Rare Diseases, Epidermolysis … Type: | 0 | 0 | 0 | 10 |
 | VIVOLTA Guiding the body to heal itself VIVOLTA is the healthcare industry’s trusted partner for contract development and manufacturing of electrospun medical products that guide the body to heal itself. Founded in 2008, we leverage our proud heritage as high-performance electrospinning equipment designer now as a leading CDMO for electrospun medical devices and drug delivery systems. Electrospinning, Nanotechnology, Biomaterials, MedTech, Medical Devices, Tissue Engineering Scaffolds, Medical Solutions, Polymers, Nanofibers, GMP, Scalable Manufacturing, Co-Development, Regenerative Medicine, Drug Delivery Solutions, Nanofibers, Tissue Engineering, Medical Electrospinning, Cardiovascular Devices, Sports Medicine Devices, General Surgery Soft Tissue Reconstruction, and MediSpin Type: | 0 | 0 | 0 | 31 |
 | Genote MUSIC MEETS SCIENCE GenoteTM distributes Health Music protocols customized to address educational, therapeutic, and wellbeing goals. Through 30 years of research and development, Genote holds a proprietary method for music's relationship to specific responses of the mind and body. Health Music began its conceptual development when a group of physicians, musicians, and psychologists gathered around the idea to research the validity of a new paradigm in the implementation of music in health: offering music as a personalized health tool. Health Music began evaluating the relationship between structural music elements, the body and the mind (Structured Music Protocol). Their scientific configuration … Type: | 0 | 0 | 0 | 2 |
 | Eye Center of Texas At Eye Center of Texas, the physicians are committed to providing optimal care and attention to our patients. Eye Center of Texas is a medical ophthalmology practice with 5 Board Certified Ophthalmologist and 10 Therapeutic Optometrists. Our physicians are committed to providing optimal care and attention to our patients and work closely with referring physicians. We specialize in medical and surgical eye care in the Houston and surrounding areas with 6 locations: •Bellaire/Houston •Pasadena •Clear Lake •Sugar Land •Katy •The Woodlands/Conroe. Cataract, Retina, LASIK, EVO ICL, Cross Linking, Premium IOLs, Dry Eye, Glaucoma, Laser Assisted Cataract Surgery , Cornea , … Type: | 0 | 0 | 0 | 70 |
 | Scaleo Medical SCALEO® Medical conceptualizes, develops and manufactures high-tech CE certified medical devices. Our goal is to build a successful and high technology company in the medical field, providing the best care and effective product solutions for the nursing staff and the patients. SCALEO Medical invents, develops and manufactures innovative products in the fields of patient transfer and hygiene, respiratory and medical weighing equipments. We are committed to helping our patients by developing safer and more effective products for more specialized care. We want to highlight quality products and references that will convince by their efficiency and reliability. We are committed to … Type: | 2 | 0 | 2 | 40 |
 | Boundless Bio Unbound by convention, bound to save lives Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence. When DNA in cancer cells comes off chromosomes, “extrachromosomal DNA (ecDNA),” it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes, driving cancer cells to grow and allowing them to resist treatment. At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells’ ability to employ ecDNA to survive. Our Culture: At Boundless, you’ll … Type: | 3 | 0 | 1 | 83 |
 | ImmunXperts, a Q2 Solutions Company Your partner in immunology projects! ImmunXperts a Q2 Solutions Company, your partner for what’s next in assay and biomarker development, advanced laboratory testing, and translational immunology. ImmunXperts brings an unrivaled ability to efficiently develop immunogenicity and immuno-oncology in vitro assays – to address both wanted and unwanted immunity for novel modalities. Immunogenicity Assessment, Immune Academy, Training, Consultancy, immuno-oncology, Cell Therapy, In vitro, assay development, Primary cells, Immunogenicity, and Immunology Type: | 1 | 0 | 0 | 24 |
 | Makex co.,ltd. Makex CO.,LTD. Supply the 3D Desktop Printer for 5years experience, CE certificated,near Ningbo and Shanghai port,this is how we keep good quality and competitice prices for global valued customers. Our main products 3D Printer Use DLP tech data suit for Jewelry printing with Kinds of resin,create unique pieces of jewelry quickly and effectiv. With the high precision,low cost,high efficiency and consistent oral date with standardized production can be suit for many dentistry fields,such as Surgical Drill Guides,Orthodontics,Denture base,Removable Die,Night Guard,Dental Crown,Denture & Functioning transition teeth.Models. Also suit for the model,eductation,etc. 3d printer, 3d desktop printer, DLP PRINTER, JEWELRY 3D PRINTING, … Type: | 1 | 0 | 1 | 3 |
 | TG Therapeutics, Inc. TG is a biopharmaceutical company focused on the development of novel treatments for B-cell diseases. TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS). Biotechnology, hematological malignancies, non-Hodgkin's lymphoma, multiple sclerosis, b-cell diseases, ublituximab, and umbralisib Type: | 0 | 0 | 0 | 384 |
 | 3Brain AG We empower researchers to explore intelligent biological networks by linking them to information technology. 3Brain developed and distributes the world’s first commercial CMOS-based high-resolution Microelectrode Array (MEA), a Biosensor integrating thousands of tiny electrical sensors in a small area. Our Biosensor allows non-invasive (in vitro) investigations of electrogenic cells, such as neurons, cardiac and muscle cells. The technology can be used to investigate electroactive cells' fundamental properties (e.g., neural code for learning and memory), to study and find new treatments to different types of diseases (e.g. Alzheimer and epilepsy) and to assess compounds/chemical toxicity. Microelectrode Arrays, High Resolution Electrophysiology, Electrophysiology … Type: | 1 | 0 | 1 | 54 |
 | Nagi Bioscience in vivo testing at the in vitro scale Nagi Bioscience is a pioneering high-tech startup developing NextGen laboratory equipment to unlock the full potential of alternatives to animal testing. Located in the heart of the Swiss "Health Valley”, we work for the transformation of biological testing standards providing cutting-edge equipment to achieve faster, scalable, more efficient and ethical methods. Under the motto “in vivo testing at the in vitro scale”, our technologies are accelerating drug development pipelines and introducing new toxicology testing standards revolutionizing pharmaceutical, cosmetic, and agro-chemical industries among others. Our approach? To unlock the full potential of small … Type: | 3 | 2 | 2 | 29 |
 | Aspivix Together, Re-imagining Gynecology with "Gentle" in Mind. Aspivix is a medical device company in women’s health, based in Switzerland, developing next-generation devices for gynecology. Our flagship product, CarevixTM, is the world’s first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology, including IUD insertion, hysteroscopy, cervical biopsies, fertility treatments, and more. CarevixTM is a medical device that has received in 2023 FDA-clearance for the US market, as well as the CE-Mark for the European countries. CarevixTM study published in the international journal, Contraception, in March 2023 demonstrated superiority over the use … Type: | 10 | 2 | 9 | 15 |
 | TRON-Mainz Science in Translation - We put inspiration into practice, finding viable solutions to complex challenges. Our mission is to turn scientific breakthroughs into progress for patients. TRON is a non-profit research institute that pursues new diagnostics and drugs for the treatment of cancer and other diseases with a high medical need. We aim to bridge the gap between fundamental science at universities and market-oriented research in the pharmaceutical industry. We turn innovative scientific concepts into treatments ready for clinical testing, thereby accelerating the translation of discoveries into new diagnostics and therapies for patients. We focus our transdisciplinary competencies in genomics … Type: | 2 | 0 | 2 | 165 |
 | Sonata Therapeutics Sonata Therapeutics is a new, Boston-based Flagship Pioneering company revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. Our product-platform creates drugs based on a systematic, comprehensive characterization of the microenvironment in diseases with high unmet medical need. Through our pioneering science, we identify new targets for therapeutics that induce the release of a programmed diversity of signals with the potential for significant patient impact. Our employees are exceptionally passionate, accountable, collaborative, and innovative. Sonata Therapeutics was founded by Flagship Pioneering, an organization dedicated to the origination and development of first-in-category life sciences … Type: | 7 | 0 | 7 | 44 |
 | Intravacc Innovating vaccines to reduce human diseases. Part of Utrecht Science Park Bilthoven Even the most promising vaccines don’t always make it out of the laboratory into large-scale production. We at Intravacc are fully aware of the challenges on the long road of vaccine development. We substantially reduce the risks and costs involved with developing vaccines. How? By bridging the gap between your concept and late stage clinical studies. As an established independent CDMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials … Type: | 2 | 0 | 0 | 63 |
 | Arvinas Leading the way in targeted protein degradation therapeutics Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting estrogen receptor for patients with locally advanced or … Type: | 4 | 0 | 2 | 444 |
 | Kymab Ltd Kymab, a Sanofi company, based in Cambridge UK, is working to provide novel solutions in drug and vaccine development. Kymab, a Sanofi company, is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available. Kymab’s platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with … Type: | 4 | 1 | 0 | 39 |
 | UNIVERCELLS For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designed and produced. At Univercells, we believe in the power of small adaptations to drive big change. We embrace the spirit of evolution in everything we do. We are biotech innovators. We are scientists and entrepreneurs creating transformative platforms for the pharmaceutical and biotech industry, through technology, bioprocess know-how and entrepreneurial spirit. Biotechnology, mRNA, CDMO, and Services Type: | 4 | 1 | 3 | 176 |
 | ReCode Therapeutics Powering the next wave of genetic medicines through superior delivery ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. RNA Therapies, Genetic Medicines, Non-Viral Lipid Nanoparticles, Genetic Respiratory Disease, Cystic Fibrosis, Primary Ciliary Dyskinesia, and Biotechnology Type: | 4 | 1 | 4 | 120 |
 | BioCentriq Manufacturing Partner for Cell Therapy Process Development and Clinical Production BioCentriq is an established, highly collaborative, global cell therapy CDMO. The company has been successfully manufacturing drug products for use in human clinical trials since 2022. In June of 2023, BioCentriq launched its LEAPTM Advanced Therapy Platform which helps cell therapy developers move from contract to clinic in as short as six months. With industry recognized scientists, engineers, analysts, and manufacturing specialists, established quality systems and modern infrastructure, BioCentriq is a proven strategic partner for the development and manufacturing of both autologous and allogeneic cell therapy products. The company was … Type: | 2 | 0 | 1 | 58 |
 | Century Therapeutics, Inc Harnessing the power of adult stem cells to develop curative therapies for cancer and autoimmune diseases Our genetically engineered, iPSC-derived cell products are designed to specifically target hematologic and solid tumor cancers, with a broadening application to autoimmune diseases. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of … Type: | 2 | 0 | 0 | 182 |
 |  Gyroscope Therapeutics Vision for Life: Developing gene therapies and delivery technologies for eye diseases. About Gyroscope Therapeutics, a Novartis company: Gyroscope Therapeutics is a clinical-stage gene therapy company developing gene therapy beyond rare disease to treat diseases of the eye that cause vision loss and blindness. The company was acquired by Novartis, a leading global medicines company, in February 2022. Gyroscope’s lead investigational gene therapy, GT005, is currently being evaluated in Phase II clinical trials for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness. GT005 has received Fast Track designation from the U.S. … Type: | 1 | 1 | 0 | 49 |
 | OxSonics Therapeutics Tackling the toughest cancers. We’re OxSonics, a pioneering clinical-stage therapeutics company committed to developing a ground-breaking platform technology to make anti-cancer drugs smarter, act faster and, above all, work better. Our SonoTran® Platform has been designed to actively enhance the delivery of oncology drugs into solid tumours. SonoTran® is drug agnostic and requires no drug reformulation enabling its use with both existing and novel therapies. We have our own development programs as well as collaborations with Pharmaceutical and biotech companies to work to bring smarter, faster and better therapies to as many patient groups as possible. Drug Delivery, Oncology, Medical … Type: | 1 | 0 | 0 | 18 |
 | Kyowa Kirin, Inc.- U.S. Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives. Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes offices in Princeton, NJ; Toronto, Canada and a research facility in La Jolla, CA. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. Our growth … Type: | 3 | 0 | 3 | 683 |
 | Albireo Pharma, Inc. On March 2, 2023, Albireo was acquired by Ipsen, strengthening Ipsen’s rare disease portfolio with promising therapeutics for pediatric and adult rare liver diseases. Albireo Pharma is a rare disease company focused on the development of novel bile acid modulators to treat pediatric and adult liver diseases. Albireo’s lead product, Bylvay, was approved by the U.S. FDA as the first drug for the treatment of pruritus in all types of progressive familial intrahepatic cholestasis (PFIC), and in Europe for the treatment of PFIC. Bylvay is also being developed to treat other rare pediatric cholestatic liver diseases with a completed Phase … Type: | 2 | 2 | 1 | 106 |
 | Adan Medical Innovation Improving anaphylaxis management Adan Medical Innovation is a company focused on the improvement of the quality of life of patients that suffer from anaphylaxis, a severe allergic reaction. To achieve this, we have formed a group of experts in different fields (physicians specialized in Allergy and Internal Medicine, business development, patent and regulatory health technologies issues, engineers, information technologies), even including patients among us, and we are working together to offer the best solutions for these patients. The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays two different products in its pipeline: AnAPPhylaxis, a … Type: | 9 | 2 | 5 | 5 |
 | TriSalus Life Sciences An immunotherapy company working to improve the lives of patients living with liver and pancreatic tumors TriSalus Life Sciences is an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors. Type: | 0 | 0 | 0 | 116 |
 | OMass Therapeutics OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona Ltd and Oxford Science Enterprises. Type: | 13 | 3 | 5 | 80 |
 | Shorla Oncology At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. At Shorla Oncology we develop and commercialize innovative oncology drugs. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments. Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical … Type: | 8 | 2 | 5 | 33 |
 | SiriusXT Whole-Cell Nano-Tomography SiriusXT has developed and manufactures a soft x-ray microscope (the SXT system), which is marketed primarily to researchers working in disease research and drug discovery. The core technology, underpinning the SiriusXT microscope is a vacuum-based laser-produced plasma (LPP) soft x-ray light source. Soft x-ray tomography is essentially a CT scan of the cell, and is critical to life scientists looking to image the 3D internal structure of an entire cell in its native fully hydrated state. The SXT system is used by disease researchers, pharmaceutical companies, bio-technologists and clinicians to aid the understanding of disease pathways, protein-drug interactions … Type: | 0 | 0 | 0 | 27 |
 | AuriGen Medical Delivering Hope to the Heart of our Patients AuriGen Medical are an EUeic supported medical device start up, developing the next generation in left atrial appendage implant technology for the treatment of medication resistant longstanding persistent atrial fibrillation. #EUeic #eicAccelerator Type: | 1 | 1 | 0 | 17 |
 | CroiValve Treating Heart Valve Disease CroíValve is an early-stage medical device company developing a unique transcatheter device to repair the tricuspid valve. Type: | 2 | 2 | 1 | 38 |
 | Daré Bioscience, Inc. Daring to be different Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. With eight potentially first-in-class women’s health products in development, we are committed to bring to market differentiated products designed to expand treatment options, improve outcomes, and facilitate a better quality of life for women. Vaginal drug delivery is often the optimum delivery approach to achieve these objectives, and IVR technology has become one of our preferred investigational platforms. Our portfolio features innovative IVR technologies including our non-hormonal contraceptive Ovaprene®, which we believe has the potential to disrupt … Type: | 6 | 0 | 5 | 26 |
 | AOA Dx Revolutionizing early diagnosis of Ovarian Cancer AOA Dx is developing the next frontier in early-stage cancer detection for women through its pioneering work in glycolipids and proprietary biomarker technology. Our revolutionary tumor marker ganglioside platform, GlycoLocateTM, is paving the way for life-saving early cancer detection. In a first of its kind, AOA Dx is developing AKRIVIS GDTM, an early-stage liquid biopsy test for ovarian cancer, that has proven excellent sensitivity and specificity in a recent study. We foresee novel tumor biomarker gangliosides as the future for diagnosis, prognosis, monitoring, and eventually targeted therapies across multiple cancers. AOA Dx was co-founded … Type: | 6 | 0 | 6 | 37 |
 | Early Charm Forging a radically new commercial path for scientific discoveries. We license intellectual property from institutions and convert it into products that we manufacture in the Pigtown neighborhood of Baltimore Converting Science into Business, Entrepreneurship, Research, drug design, machine vision, custom materials, and aquaculture technologies Type: | 1 | 1 | 1 | 26 |
 | Endocrinology Advisor Endocrinology Advisor is an online resource that provides health care professionals with comprehensive information on important principles of care in endocrinology as well as up-to-date clinical news on the diagnosis and treatment of endocrine conditions. Our mission is to offer the most recent clinical research news and evidence-based guidance that will aid health care professionals in the management of endocrine conditions. Type: | 0 | 0 | 0 | 2 |
 | Onalabs Inno-Hub The future of biomonitoring Point-of-Care (POC) technologies, designed to provide rapid clinical diagnosis at, or near the site of patient care, has the potential to sense changes in well-known biomarkers used already to monitor patients with chronic cardiac and respiratory diseases. However, they need to be measured in blood, which limit their use only in medical institutions. Our non-invasive products based on wearable formats will empower the patients and their families to measure relevant biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier (self-)management strategies, resulting in shorter … Type: | 9 | 2 | 7 | 22 |
SMB